New math could make clinical trials more accurate
NCT ID NCT03964402
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study aims to create better statistical methods for determining how many participants are needed in clinical trials. It accounts for differences among patients, such as varying health risks or treatment responses. The goal is to make trials more reliable without testing any specific drug or therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how clinical trials are designed, making them more reliable and efficient for testing new treatments.
- What could go wrong
- This is a statistical methods study, not a treatment trial. It does not test any drug or therapy, so it cannot directly help patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL TRIALS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Bergonié, Comprehensive Cancer Center
Bordeaux, 33400, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A custom-shaped healing cap may keep gums and bone in better shape after tooth extraction and implant placement
- New website aims to close cancer care gap for black patients
- Brain training may ease chemo brain in breast cancer patients
- Stem cells injected into spine: hope for paralysis?
- Can a simple survey fix clinical trial diversity?